Symposium Proceedings

View Video* of the Conference

Concurrent Sessions

Day 1 Keynote and Plenary Session

Day 2 Plenary Sessions

*where presenter permission was granted

View Pictures of the Conference

Photographs by Ed Cunicelli

Friday, May 7, 2021

Agenda with Presentations

Time
Session
7:30 am EDT

Log-in to Virtual Conference - Visit Virtual Exhibit Hall, Posters, Concurrent Sessions / Network 

9:00 am EDT

Welcome and Introductions

J. Larry Jameson, MD, PhD | University of Pennsylvania
Madeline Bell | Children’s Hospital of Philadelphia
Robert H. Vonderheide, MD, DPhil | Abramson Cancer Center

9:15 am EDT

Plenary Session 1: CARS of Today and Tomorrow

Moderator: Richard T. Maziarz, MD | Oregon Health & Science University

Lymphoma

David G. Maloney, MD, PhD | Fred Hutchinson Cancer Research Center- PRESENTATION

Myeloma

Alfred L. Garfall, MD, MS | Penn Medicine - PRESENTATION

ALL

Terry J. Fry, MD | Children’s Hospital Colorado (consent to post not granted)

Q&A Discussion

10:15 am EDT

Plenary Session 2: Overcoming Resistance to Monotherapy CAR's

Moderator: Shannon L. Maude, MD, PhD | Children’s Hospital of Philadelphia

CHOP/Penn 19+22 Trials

Noelle V. Frey, MD, MSCE | Penn Medicine - Coming Soon

AUTO3 and Beyond - Experience with Co-Targeting of CD19 and CD22 in DLBCL and B-ALL

Martin Pule, MB BCh, MRCP | University College London  (consent to post not granted)

Bispecific CAR 19-22 and Sequential CAR22 Rescue- the Experience of a Few Prodigies

David B. Miklos, MD, PhD | Stanford University - PRESENTATION

Q&A Discussion

11:15 am EDT

Plenary Session 3: Cell Therapy During the Pandemic

Moderator: David L. Porter, MD | Penn Medicine

Clinical Experience CHOP

Shannon L. Maude, MD, PhD | Children’s Hospital of Philadelphia - Coming Soon

CAR T in NYC During the Height of the Disaster

Gunjan L. Shah, MD | Memorial Sloan Kettering Cancer Center- PRESENTATION

Challenges Providing Donor Hematopoietic Products Globally During COVID-19

Steve Devine, MD | Be The Match BioTherapies - PRESENTATION

Development of SARS-CoV2 T Cell Products for Administration After BMT 

Catherine M. Bollard, MD, MBChB | Children's National Hospital - PRESENTATION

Q&A Discussion

12:30 pm EDT

Network / Visit Exhibits / View Posters / Catch up on Pre-Recorded Concurrent Sessions

3:00 pm EDT

Plenary Session 4: Globalization of CAR T Cell Therapies India, Costa Rica and Brazil

Moderator: Bruce L. Levine, PhD | Penn Medicine

Bringing CAR-T Cells to India

Siddhartha Mukherjee, MD, DPhil | Columbia University, Herbert Irving Comprehensive Cancer Center - Coming Soon

Implementing CAR-T Cell Therapies in Costa Rica

Román Macaya Hayes, PhD | Costa Rican Social Security System - PRESENTATION

Developing CART-Cells Therapies in Brazil

Renato Luiz Guerino Cunha, MD, PhD | Hospital das Clínicas de Ribeirão Preto, Brazil- PRESENTATION

Q & A Discussion
4:00 pm EDT

Future of Cell and Gene Therapy

Carl H June, MD | Penn Medicine

4:30 pm EDT

Adjourn